Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Other Accumulated Expenses (2023 - 2025)

Onconetix (ONCO) has disclosed Other Accumulated Expenses for 2 consecutive years, with $220331.0 as the latest value for Q3 2024.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $220331.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $220331.0, a N/A change, with the full-year FY2023 number at $265849.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $220331.0 for Q3 2024 at Onconetix, up from $100000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $265849.0 in Q4 2023 to a low of $50000.0 in Q1 2024.